We are monitoring the impact of COVID-19 on Viscosupplementation Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 10407
Share on
Share on

Global Viscosupplementation Market Size, Share, Trends, COVID-19 Impact & Growth Analysis Report – Segmented By product, end-user, and Region (North America, Europe, Asia Pacific, Latin America, The Middle East, and Africa) – Industry Forecast (2021 to 2026)

Pulished: April, 2021
ID: 10407
Pages: 190

Viscosupplementation Market Size (2021 to 2026)

During the forecast period, the global viscosupplementation market size is forecasted to grow at a CAGR of 9.45%. The market size is estimated to value USD 7.08 billion by 2026 and USD 4.51 billion in 2021.

Viscosupplementation is a medical procedure to treat people suffering from osteoarthritis in hip, knee, ankle, and spine arthritis. Generally, at first, injecting numbing medicine into the space around the knee joint removes excess fluid, causing the joint to swell and later hyaluronic acid into space inside the joint. The synovial fluid in the joints loses its capability to lubricate the joint. The liquid is a thick gel-like substance softening the joints and provides lubrication to reduce friction. People suffering from osteoarthritis have less hyaluronic acid in their joints. They have symptoms like pain, swelling, and stiffness. As soon as the hyaluronic acid is injected into the joints, the pain doesn't reduce right away. Once done with the full course treatment, they may notice some pain relief.

MARKET TRENDS:

Y-O-Y growth in the adoption of Viscosupplementation treatment by patients is majorly accelerating the demand for the global viscosupplementation market.

Advancements in the development of hyaluronic acid-based therapy and the rising popularity of lifestyle-induced disorders are further adding a significant boost to the market growth. In addition, an increase in product launches and regulatory approvals are also increasing the demand levels for the viscosupplementation.

Y-O-Y growth in the incidence of osteoarthritis is another significant factor accelerating the market growth.

Osteoarthritis (OA) is seen mainly in people aged 60 years and above. The geriatric population is much likely to prone to osteoarthritis and noticed in 10% of men and 13% of women in a survey. According to the Population Reference Bureau, the American population aged 65 years and older and is projected to rise two times from 46 million in 2016 to 98 million by 2060. Patients have prescribed osteoarthritis take hyaluronic acid injections to get more relief than simple analgesics or drug treatment.

Additionally, growth in the prevalence of knee osteoarthritis and hip osteoarthritis is further driving demand for viscosupplementation products. For example, 10% of men and 13% of women suffer from knee osteoarthritis, aged around 60. Thus, globally, there are lucrative opportunities for the viscosupplementation market by ambulatory surgical centers. Ambulatory surgical centers provide treatment under a licensed physician's direction to medical care for needy patients.

MARKET RESTRAINTS:

However, fluctuations in the availability of the products are slowly impeding the growth rate of the market. In addition, long-term use of these products results in side effects, which is also a factor degrading the market demand.  Lack of safety and efficiency associated with viscosupplementation products and complex regulatory processes are other significant issues that the global viscosupplementation market is currently facing.

COVID-19 Impact on the global viscosupplementation market:

COVID-19 has disrupted all the sectors in unprecedented ways. World Health Organization declared the spread of COVID 19 as a pandemic. The viscosupplementation market shares were at a high pace before the start of COVID 19. Since the beginning of COVID 19, the market shares were going down, which are expected to hike by 2021. All government authorities have imposed a lockdown and a ban on flights during the first half of 2020. During this time, all the manufacturing units and the supply chain were paused, which declined the market's growth rate. In the meanwhile, some key players of the viscosupplementation market, such as Fidia Framaceutici S.P.A had introduced TRILUON product, which used to treat osteoarthritis pain of the knee. Many key players focus on developing new products and promoting them through different platforms to grow the market. 

REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2020 to 2026

Base Year

2020

Forecast Period

2021 to 2026

Segments Covered

By Product, End-User, and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

 

This research report on the global viscosupplementation market has been segmented and sub-segmented based on the product, end-user, and region.

Viscosupplementation Market – By Product:

  • Single Injection
  • Three Injection
  • Five Injection

Based on the product, the three injections segment is expected to account for the maximum share during the forecast period due to the high adoption and commercialized products. On the other hand, the single-injection segment is predicted to register a healthy CAGR between 2021 to 2026 due to the benefits of shorter regimens, no need to visit the hospital regularly, and less pain. 

Viscosupplementation Market – By End-Use:

  • Hospitals
  • Orthopedic Clinic/ Ambulatory Surgical Centers (ASCs)

Based on end-user, the segment orthopedic clinics/Ambulatory Surgical Centers (ASCs) had accounted for the highest number of shares in 2020 and is predicted to continue the domination throughout the forecast period. Orthopedic clinics and ambulatory surgical centers worldwide provide various medical services to create awareness and promote treatment at an affordable cost.

Viscosupplementation Market – By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • The Middle East and Africa

Geographically, the North American viscosupplementation market held with the largest shares of the global market in 2019 and is expected to continue the same in the coming years. A rise in the geriatric population leads to an increase in osteoarthritis incidence, which boosts demand for joint-injectable products. The population of Americans aged 65 or older is much higher than in any other region; this will help grow the viscosupplementation market in North America. This regional market was the most lucrative application for hyaluronic acids in 2019 to manage viscosupplements. A rise in the geriatric population leads to an increase in osteoarthritis incidence, which boosts demand for joint-injectable products.

The Asia Pacific viscosupplementation market is estimated to be the fastest-growing region globally during the forecast period. Increasing awareness of viscosupplementation effectiveness and rising demand for non-surgical treatments are significant reasons for market growth. Due to emerging countries such as China, India, South Korea, and Japan, increasing healthcare facilities and infrastructure growth helped the market grow. Moreover, in countries like South Korea, low governing limitations contributed to the rise of the Asia-Pacific viscosupplementation market. North Korea had named viscosupplementation as a specialized medication. Eventually, in countries like India and China, the low manufacturing cost had grabbed the pharmaceutical and biotechnological giants to the Asia-Pacific region. Only in India, approximately more than 260 thousand people were affected due to rheumatoid arthritis, fueling the Asia-Pacific viscosupplementation market. Thus, the Asia-pacific region is expected to be a cost-effective market. An increase in awareness about the effectiveness of viscosupplementation and improvement of healthcare infrastructure in emerging countries such as Japan, South Korea, India, and China are driving significant growth to this regional market. The low regulatory barrier in South Korea and other countries developing a foreseen for attractive opportunities to set afoot by key players in those countries. 

The European viscosupplementation market is predicted to grow at a promising rate between 2021 to 2026. The increase in patient awareness about the effective treatment for knee osteoarthritis fuel the market growth. The rising obesity rates had helped the viscosupplementation market growth. The cost-effectiveness of the treatment and the growing medical technology industry had raised the viscosupplementation market in Europe. Moreover, the rapidly increasing aging population with osteoarthritis indications helped the market's growth. Since the viscosupplementation had a strong safety profile and the best physicochemical properties of hyaluronic acid-based viscosupplementation injections helped the market. Consumers of the European region view pricing and reimbursement as decisive factors for choosing hyaluronic acid treatment. In other parts of the world, the rating will be based on the safety of the world. To avoid knee surgeries as possible is the main motto of doctors, which boosts demand for pain management by viscosupplements.

VISCOSUPPLEMENTATION MARKET SHARE INSIGHTS:

The global viscosupplementation market is competitive, and several new players have entered this market in the recent past. To neutralize the competition and strengthen their position, the leading companies invest in R&D and focus on the new product launches.

Manufacturers such as Sanofi S.A., Zimmer Biomet Holdings Inc., Bioventus LLC, Anika Therapeutics Inc., Fidia Farmaceutici S.p.A., Ferring B.V., Seikagaku Corporation, Chungai Pharmaceutical Co., Ltd., OrthogenRx Inc., and Mylan N.V are playing the leading role in the global viscosupplementation market.

KEY HAPPENINGS IN THIS MARKET:

  • In April 2018, for product JTA-004 intra-articular injection for knee O.A., clinical trials were completed by Bone Therapeutics S.A. It is a protein solution enhancement that is supplemented with hyaluronic acid and clonidine.
  •  In June 2019, Hyalofast, a new product showcased by Anika Therapeutics, Inc., repaired the cartilages at ICRS (International cartilage regeneration and joint preservation society).
  1. Introduction
    1. Market Definition
    2. Study Deliverables
    3. Base Currency, Base Year and Forecast Periods
    4. General Study Assumptions
  2. Research Methodology
    1. Introduction
    2. Research Phases
        1. Secondary Research
        2. Primary Research
        3. Econometric Modelling
        4. Expert Validation
    3. Analysis Design
    4. Study Timeline
  3. Overview
    1. Executive Summary
    2. Key Inferences
    3. New Developments
  4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
    1. Market Drivers
    2. Market Restraints
    3. Key Challenges
    4. Current Opportunities in the Market
  5. Market Segmentation
    1. By Product
      1. Single Injection
      2. Three Injection
      3. Five Injection
      4. Y-o-Y Growth Analysis, By Product
      5. Market Attractiveness Analysis, By Product
      6. Market Share Analysis, By Product
    2. By End-User
      1. Hospitals
      2. Orthopedic Clinic/ Ambulatory Surgical Centers (ASCs)
      3. Y-o-Y Growth Analysis, By End-User
      4. Market Attractiveness Analysis, By End-User
      5. Market Share Analysis, By End-User
  6. Geographical Analysis
    1. Introduction    
      1. Regional Trends   
      2. Impact Analysis    
      3. Y-o-Y Growth Analysis        
        1. By Geographical Area
        2. By Product
        3. By Distribution Channel
      4. Market Attractiveness Analysis      
        1. By Geographical Area
        2. By Product
        3. By Distribution Channel
      5.      Market Share Analysis   
        1. By Geographical Area
        2. By Product
        3. By Distribution Channel
    2. North America
      1. Introduction
      2. US
      3. Canada
    3. Europe
      1. Introduction
      2. UK
      3. France
      4. Spain
      5. Germany
      6. Italy
    4. Asia-Pacific
      1. Introduction
      2. India
      3. China
      4. Japan
      5. South Korea
      6. Australia
    5. Latin America
      1. Introduction
      2. Brazil
      3. Argentina
      4. Mexico
    6. Middle East & Africa
      1. Introduction
      2. Middle East
      3. Africa
  7. Strategic Analysis
    1. PESTLE analysis
      1. Political
      2. Economic
      3. Social
      4. Technological
      5. Legal
      6. Environmental
    2. Porter’s Five analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Consumers
      3. Threat of New Entrants
      4. Threat of Substitute Products and Services
      5. Competitive Rivalry within the Industry
  8. Market Leaders' Analysis
    1. Sanofi S.A.
      1. Overview
      2. Product Analysis
      3. Strategic Evaluation and Operations
      4. Financial analysis
      5. Legal issues
      6. Recent Developments
      7. SWOT analysis
      8. Analyst View
    2. Zimmer Biomet Holdings Inc.
    3. Bioventus LLC
    4. Anika Therapeutics Inc.
    5. Fidia Farmaceutici S.p.A.
    6. Ferring B.V.
    7. Seikagaku Corporation
    8. Chungai Pharmaceutical Co., Ltd.
    9. OrthogenRx Inc.
    10. Mylan N.V
  9. Competitive Landscape
    1. Market share analysis
    2. Merger and Acquisition Analysis
    3. Agreements, Collaborations and Joint Ventures
    4. New Product Launches
  10. Market Outlook and Investment Opportunities
  11. Appendix
    1. List of Tables
    2. List of Figures 
  • Global, and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of product and end-user along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Global Viscosupplementation Market, By Region, From 2021 to 2026 (USD Million)
  2. Global Viscosupplementation Market, By Product, From 2021 to 2026 (USD Million)
  3. Global Single Injection Market, By Region, From 2021 to 2026 (USD Million)
  4. Global Three Injection Market, By Region, From 2021 to 2026 (USD Million)
  5. Global Five Injection Market, By Region, From 2021 to 2026 (USD Million)
  6. Global Viscosupplementation Market, By End-User, From 2021 to 2026 (USD Million)
  7. Global Hospitals Market, By Region, From 2021 to 2026 (USD Million)
  8. Global Orthopedic Clinic/ Ambulatory Surgical Centers (ASCs) Market, By Region, From 2021 to 2026 (USD Million)
  9. North America Viscosupplementation Market, By Product, From 2021 to 2026 (USD Million)
  10. North America Single Injection Market, By Region, From 2021 to 2026 (USD Million)
  11. North America Three Injection Market, By Region, From 2021 to 2026 (USD Million)
  12. North America Five Injection Market, By Region, From 2021 to 2026 (USD Million)
  13. North America Viscosupplementation Market, By End-User, From 2021 to 2026 (USD Million)
  14. North America Hospitals Market, By Region, From 2021 to 2026 (USD Million)
  15. North America Orthopedic Clinic/ Ambulatory Surgical Centers (ASCs) Market, By Region, From 2021 to 2026 (USD Million)
  16. United States Viscosupplementation Market, By Product, From 2021 to 2026 (USD Million)
  17. United States Viscosupplementation Market, By End-User, From 2021 to 2026 (USD Million)
  18. Canada Viscosupplementation Market, By Product, From 2021 to 2026 (USD Million)
  19. Canada Viscosupplementation Market, By End-User, From 2021 to 2026 (USD Million)
  20. Europe Viscosupplementation Market, By Product, From 2021 to 2026 (USD Million)
  21. Europe Single Injection Market, By Region, From 2021 to 2026 (USD Million)
  22. Europe Three Injection Market, By Region, From 2021 to 2026 (USD Million)
  23. Europe Five Injection Market, By Region, From 2021 to 2026 (USD Million)
  24. Europe Viscosupplementation Market, By End-User, From 2021 to 2026 (USD Million)
  25. Europe Hospitals Market, By Region, From 2021 to 2026 (USD Million)
  26. Europe Orthopedic Clinic/ Ambulatory Surgical Centers (ASCs) Market, By Region, From 2021 to 2026 (USD Million)
  27. U.K. Viscosupplementation Market, By Product, From 2021 to 2026 (USD Million)
  28. U.K. Viscosupplementation Market, By End-User, From 2021 to 2026 (USD Million)
  29. Germany Viscosupplementation Market, By Product, From 2021 to 2026 (USD Million)
  30. Germany Viscosupplementation Market, By End-User, From 2021 to 2026 (USD Million)
  31. France Viscosupplementation Market, By Product, From 2021 to 2026 (USD Million)
  32. France Viscosupplementation Market, By End-User, From 2021 to 2026 (USD Million)
  33. Italy Viscosupplementation Market, By Product, From 2021 to 2026 (USD Million)
  34. Italy Viscosupplementation Market, By End-User, From 2021 to 2026 (USD Million)
  35. Spain Viscosupplementation Market, By Product, From 2021 to 2026 (USD Million)
  36. Spain Viscosupplementation Market, By End-User, From 2021 to 2026 (USD Million)
  37. Asia Pacific Viscosupplementation Market, By Product, From 2021 to 2026 (USD Million)
  38. Asia Pacific Single Injection Market, By Region, From 2021 to 2026 (USD Million)
  39. Asia Pacific Three Injection Market, By Region, From 2021 to 2026 (USD Million)
  40. Asia Pacific Five Injection Market, By Region, From 2021 to 2026 (USD Million)
  41. Asia Pacific Viscosupplementation Market, By End-User, From 2021 to 2026 (USD Million)
  42. Asia Pacific Hospitals Market, By Region, From 2021 to 2026 (USD Million)
  43. Asia Pacific Orthopedic Clinic/ Ambulatory Surgical Centers (ASCs) Market, By Region, From 2021 to 2026 (USD Million)
  44. Japan Viscosupplementation Market, By Product, From 2021 to 2026 (USD Million)
  45. Japan Viscosupplementation Market, By End-User, From 2021 to 2026 (USD Million)
  46. China Viscosupplementation Market, By Product, From 2021 to 2026 (USD Million)
  47. China Viscosupplementation Market, By End-User, From 2021 to 2026 (USD Million)
  48. India Viscosupplementation Market, By Product, From 2021 to 2026 (USD Million)
  49. India Viscosupplementation Market, By End-User, From 2021 to 2026 (USD Million)
  50. Australia Viscosupplementation Market, By Product, From 2021 to 2026 (USD Million)
  51. Australia Viscosupplementation Market, By End-User, From 2021 to 2026 (USD Million)
  52. South Korea Viscosupplementation Market, By Product, From 2021 to 2026 (USD Million)
  53. South Korea Viscosupplementation Market, By End-User, From 2021 to 2026 (USD Million)
  54. Latin America Viscosupplementation Market, By Product, From 2021 to 2026 (USD Million)
  55. Latin America Single Injection Market, By Region, From 2021 to 2026 (USD Million)
  56. Latin America Three Injection Market, By Region, From 2021 to 2026 (USD Million)
  57. Latin America Five Injection Market, By Region, From 2021 to 2026 (USD Million)
  58. Latin America Viscosupplementation Market, By End-User, From 2021 to 2026 (USD Million)
  59. Latin America Hospitals Market, By Region, From 2021 to 2026 (USD Million)
  60. Latin America Orthopedic Clinic/ Ambulatory Surgical Centers (ASCs) Market, By Region, From 2021 to 2026 (USD Million)
  61. Brazil Viscosupplementation Market, By Product, From 2021 to 2026 (USD Million)
  62. Brazil Viscosupplementation Market, By End-User, From 2021 to 2026 (USD Million)
  63. Argentina Viscosupplementation Market, By Product, From 2021 to 2026 (USD Million)
  64. Argentina Viscosupplementation Market, By End-User, From 2021 to 2026 (USD Million)
  65. Mexico Viscosupplementation Market, By Product, From 2021 to 2026 (USD Million)
  66. Mexico Viscosupplementation Market, By End-User, From 2021 to 2026 (USD Million)
  67. Rest of Latin America Viscosupplementation Market, By Product, From 2021 to 2026 (USD Million)
  68. Rest of Latin America Viscosupplementation Market, By End-User, From 2021 to 2026 (USD Million)
  69. Middle East and Africa Viscosupplementation Market, By Product, From 2021 to 2026 (USD Million)
  70. Middle East and Africa Single Injection Market, By Region, From 2021 to 2026 (USD Million)
  71. Middle East and Africa Three Injection Market, By Region, From 2021 to 2026 (USD Million)
  72. Middle East and Africa Five Injection Market, By Region, From 2021 to 2026 (USD Million)
  73. Middle East and Africa Viscosupplementation Market, By End-User, From 2021 to 2026 (USD Million)
  74. Middle East and Africa Hospitals Market, By Region, From 2021 to 2026 (USD Million)
  75. Middle East and Africa Orthopedic Clinic/ Ambulatory Surgical Centers (ASCs) Market, By Region, From 2021 to 2026 (USD Million)
  76. Middle East Viscosupplementation Market, By Product, From 2021 to 2026 (USD Million)
  77. Middle East Viscosupplementation Market, By End-User, From 2021 to 2026 (USD Million)
  78. Africa Viscosupplementation Market, By Product, From 2021 to 2026 (USD Million)
  79. Africa Viscosupplementation Market, By End-User, From 2021 to 2026 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample